Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v1-EN
Language English English
Date Updated 2020-12-03 2020-08-05
Drug Identification Number 02446049 02446049
Brand name MEMANTINE MEMANTINE
Common or Proper name MEMANTINE MEMANTINE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06DX N06DX
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-10-26 2020-09-14
Actual start date 2020-10-26
Estimated end date 2021-01-11 2020-10-02
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments